Optimized tDCS for Fibromyalgia: Targeting the Endogenous Pain Control System
Key facts
- Who runs it
- Spaulding Rehabilitation Hospital
- Where
- Cambridge, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 116 people enrolled
- Started
- 1 May 2019
- Ended
- 26 Oct 2025
- Type of study
- Interventional, 4 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Active tDCS
- Active Exercise
- Sham tDCS
- Sham Exercise
- Record updated
- 10 December 2025
Who can take part
- Age
- 18 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Age range 18-65 years,
- Diagnosis of FM pain according to the ACR 2010 criteria (existing pain for more than 6 months with an average of at least 4 on a 0-10 VAS scale) without other comorbid chronic pain diagnosis,
- Pain resistant to common analgesics and medications for chronic pain such as Tylenol, Aspirin, Ibuprofen, Soma, Parafon Forte DCS, Zanaflex, and Codeine,
- Must have the ability to feel sensation by Von-Frey fiber on the forearm,
- Able to provide informed consent to participate in the study
Who cannot take part
- Previous significant neurological history (e.g., traumatic brain injury), resulting in neurological deficits, such as cognitive or motor deficits, as self-reported,
- Previous neurosurgical procedure with craniotomy,
- Clinically significant or unstable medical or psychiatric disorder,
- history of substance abuse within the past 6 months as self-reported (if subject reports a history of substance abuse, we will confirm using DSM V criteria),
- Severe depression (If a patient scores >30 on the Beck Depression Inventory, one will obtain clearance. If one does not pass the medical clearance, one will not be included in the study)
- Pregnancy (as the safety of tDCS in pregnant population (and children) has not been assessed (though risk is non-significant), the investigators will exclude pregnant women (and children). Women of child-bearing potential will be required to take a urine pregnancy test during the screening process and at every week of stimulation),
- Current opiate use in large doses (more than 30mg of oxycodone/hydrocodone or 7.5mg of hydromorphone (Dilaudid) or equivalent),
- Patients will be excluded when they have increased risk for exercise
Where in United States
- Spaulding Rehabilitation Hospital for Continuing CareCambridge, United States
About the trial
What the trial wants to find out
This trial aims at understanding the mechanisms of optimized transcranial direct current stimulation (tDCS) (16 tDCS sessions combined with exercise)] on pain control. Optimized tDCS can lead to stronger engagement of the endogenous pain regulatory system that will ultimately lead to increased pain relief in patients with fibromyalgia (FM). Therefore, the investigators designed a 2x2 factorial mechanistic trial [tDCS (active and sham) and aerobic exercise (AE) (active and control)] to evaluate the effects of 4 weeks of tDCS coupled with exercise on the endogenous pain regulatory system assessed by conditioned pain modulation (CPM) and central sensitization as assessed by temporal slow pain summation (TSPS), and compared to either intervention alone and to no intervention.
The 4 groups in the trial
- Active tDCS and Active ExerciseTreatment being tested
Active tDCS for 20 min Active exercise (60-70% max HR) for 30 min
Treatment: Active tDCS and Active Exercise
- Sham tDCS and Active ExerciseExisting treatment, for comparison
Sham tDCS for 20 min Active exercise (60-70% max HR) for 30 min
Treatment: Active Exercise and Sham tDCS
- Active tDCS and Sham ExerciseExisting treatment, for comparison
Active tDCS for 20 min Sham exercise (within 10% baseline HR) for 30 min
Treatment: Active tDCS and Sham Exercise
- Sham TDCS and Sham ExerciseSham treatment, for comparison
Sham tDCS for 20 min Sham exercise (within 10% baseline HR) for 30 min
Treatment: Sham tDCS and Sham Exercise
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Publications
- Brain compensatory mechanisms in depression and memory complaints in fibromyalgia: the role of theta oscillatory activity.Pain medicine (Malden, Mass.), 2024
- Optimised transcranial direct current stimulation (tDCS) for fibromyalgia-targeting the endogenous pain control system: a randomised, double-blind, factorial clinical trial protocol.BMJ open, 2019
- Record updated
- 10 December 2025